Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Four hundred ninety-eight
acetylcholinesterase
-stained suction rectal biopsies from 456 children were examined to assess the occurrence of "isolated" or "primary" intestinal neuronal dysplasia at Children's Hospital of Pittsburgh. Cases of proven Hirschsprung's disease were excluded. In 38 biopsies from 38 patients, we found a mild to moderate increase in mucosal
acetylcholinesterase
staining and abundant submucosal ganglion cells (large, irregular ganglia or at least five ganglia per HPF). This group was clinically heterogeneous with a frequent history of
prematurity
and small left colon/meconium plug syndrome, protein/formula intolerance, or obstructive anatomic gastrointestinal abnormalities. We feel that isolated "intestinal neuronal dysplasia," as diagnosed by suction rectal biopsy and the above criteria, is a descriptive biopsy appearance. Rather than characterizing a unique disease entity, it is encountered in a variety of clinical situations. Based on our observations and review of the literature, we therefore conclude that "intestinal neuronal dysplasia" not associated with Hirschsprung's disease, neurofibromatosis, or multiple endocrine neoplasia syndrome has yet to be well defined in clinical and histopathologic terms. The histologic diagnosis, at this time, should be reserved for those rare, florid cases of parasympathetic hyperganglionosis that are documented by adequate tissue sampling.
...
PMID:Intestinal neuronal dysplasia. 205 Dec 70
ABSTRACT In the present study the in vitro hypoglycemic and anti-
acetylcholinesterase
activities of hot pepper fruits (Capsicum annuum var. acuminatum L.) at different ripening stages were investigated. The mature, green-stage fruits had the highest activity against alpha-amylase and alpha-glucosidase with 50% inhibitory concentration (IC(50)) values of 55.88 and 76.11 microg/mL, respectively, while C. annuum var. acuminatum in the
prematurity
green stage exhibited the highest
acetylcholinesterase
inhibition property (IC(50) = 84.30 microg/mL), using the Ellman method. This study highlights the biochemical rationale for chemopreventive significance in health benefits when consuming this variety of pepper.
...
PMID:Influence of ripening stage on health benefits properties of Capsicum annuum var. acuminatum L.: in vitro studies. 1836 55
Background Almost 30% of the premature infants have low body weight and bone mineral density due to
prematurity
. There is no consensus of screening premature neonates for metabolic bone disease; therefore, it is important to investigate the use of bone biochemical parameters. Latest studies involved the activity of
acetylcholinesterase
as a mediator in bone remodeling. It is hypothesized that there is a possible correlation of bone biochemical biomarkers and
acetylcholinesterase
(
AChE
) activity in premature infants. Methods We studied 50 neonates (26 preterm with gestational age <32 weeks, 24 full-term). Clinical data (sex, gestational week) and anthropometric parameters (body weight) were recorded. We directly measured the bone biochemical markers in serum such as alkaline phosphatase (ALP), calcium (Ca), phosphorus (P), magnesium (Mg) and parathyroid hormone (PTH). In addition, we measured the
AChE
activity. Results ALP and parathyroid hormone levels were higher, but Ca, P and
AChE
were lower in premature neonates group compared with full-term ones. There is a significant positive correlation of gestational age with body weight, Ca and
AChE
. A significant negative correlation was observed for ALP and PTH with gestational age. Conclusions We found a gestational age-related increase of
AChE
activity. There were significant relationships between
AChE
activity with P and PTH.
...
PMID:Acetylcholinesterase activity and bone biochemical markers in premature and full-term neonates. 3042 81